extract from - http://bostonreview.net/BR35.2/spitzer.php
When we sued Glaxo, they thought we wanted money. But we only wanted them to change the way they acted. We asked them to create a Web site for the clinical testing data so that doctors and journals could make informed judgments. They agreed. The settlement became part of a longer process, a move toward substantially more disclosure when it comes to drugs and testing data.
From Glaxo’s perspective, the more data they withheld, the better it was for them. They could persuade more people to use Paxil. So, again: only government can ensure integrity, transparency, and fair dealing.
Monday, 1 March 2010
NOT for Spitzer to decide if Paxil was good/bad for teenagers - the case was about disclosure of information
extract from - http://bostonreview.net/BR35.2/spitzer.php
Here’s another story. We brought a case against GlaxoSmithKline, which was at the time marketing Paxil—an anti-depressant—as effective for teenagers. It had been approved for other purposes, but this was off-label marketing. We found that a significant number of the clinical tests they had done proved something directly at odds with their claims. It was not for me as attorney general to determine whether this drug was bad or good for teenagers, but to insist on full disclosure of critically relevant information so that doctors and journals could make that determination.
When we sued Glaxo, they thought we wanted money. But we only wanted them to change the way they acted. We asked them to create a Web site for the clinical testing data so that doctors and journals could make informed judgments. They agreed. The settlement became part of a longer process, a move toward substantially more disclosure when it comes to drugs and testing data.
From Glaxo’s perspective, the more data they withheld, the better it was for them. They could persuade more people to use Paxil. So, again: only government can ensure integrity, transparency, and fair dealing.
Here’s another story. We brought a case against GlaxoSmithKline, which was at the time marketing Paxil—an anti-depressant—as effective for teenagers. It had been approved for other purposes, but this was off-label marketing. We found that a significant number of the clinical tests they had done proved something directly at odds with their claims. It was not for me as attorney general to determine whether this drug was bad or good for teenagers, but to insist on full disclosure of critically relevant information so that doctors and journals could make that determination.
When we sued Glaxo, they thought we wanted money. But we only wanted them to change the way they acted. We asked them to create a Web site for the clinical testing data so that doctors and journals could make informed judgments. They agreed. The settlement became part of a longer process, a move toward substantially more disclosure when it comes to drugs and testing data.
From Glaxo’s perspective, the more data they withheld, the better it was for them. They could persuade more people to use Paxil. So, again: only government can ensure integrity, transparency, and fair dealing.
Eliot Spitzer: The Rules - Government’s proper role in the market
Boston Review — Eliot Spitzer: The Rules
Eliot Spitzer
Every day we read the headlines, feel the tensions, observe the consequences of the recent failures of market and government. Having a serious conversation about how to remedy these failures lies at the heart of current American politics. And that conversation should address three distinct questions:
• What are the parameters of government intervention in the marketplace? What rules should we use in deciding when the government should act, and when it should let the market take its course?
read on -
http://bostonreview.net/BR35.2/spitzer.php
Eliot Spitzer
Every day we read the headlines, feel the tensions, observe the consequences of the recent failures of market and government. Having a serious conversation about how to remedy these failures lies at the heart of current American politics. And that conversation should address three distinct questions:
• What are the parameters of government intervention in the marketplace? What rules should we use in deciding when the government should act, and when it should let the market take its course?
read on -
http://bostonreview.net/BR35.2/spitzer.php
An Overdose at 15 - Traci Johnson / Tylenol (paracetamol)?
An Overdose at 15
Johnson seemed like a good candidate for the duloxetine trial. At 5-foot-4 and 130 pounds, she was physically fit and, by all accounts, reliable and upbeat.
But during her interview, she told screeners that when she was 15, she had landed in the emergency room after overdosing on Tylenol pills and had to have her stomach cleared, according to a psychiatrist studying duloxetine who has read a report on Johnson's case. The doctor spoke on condition of anonymity because the information was considered confidential
http://66.102.9.132/search?q=cache:XZTbVB6fKjAJ:articles.latimes.com/2004/apr/02/science/sci-humantest2+%22A+Godsend,+Till+a+Life+Unravels%22&cd=1&hl=en&ct=clnk
Johnson seemed like a good candidate for the duloxetine trial. At 5-foot-4 and 130 pounds, she was physically fit and, by all accounts, reliable and upbeat.
But during her interview, she told screeners that when she was 15, she had landed in the emergency room after overdosing on Tylenol pills and had to have her stomach cleared, according to a psychiatrist studying duloxetine who has read a report on Johnson's case. The doctor spoke on condition of anonymity because the information was considered confidential
http://66.102.9.132/search?q=cache:XZTbVB6fKjAJ:articles.latimes.com/2004/apr/02/science/sci-humantest2+%22A+Godsend,+Till+a+Life+Unravels%22&cd=1&hl=en&ct=clnk
A Godsend, Till a Life Unravels - Los Angeles Times
A Godsend, Till a Life Unravels - Los Angeles Times: "A Godsend, Till a Life Unravels"
Traci Johnson joined a clinical trial of an antidepressant to pay for college. The devout woman ended up taking her own life.
THE NATION
COLUMN ONEApril 02, 2004
Alan Zarembo and Benedict Carey , Times Staff WritersINDIANAPOLIS — Traci Johnson believed it was God's plan for her to leave home to attend a tiny Bible college here -- and she prayed every day for the Lord to provide for her tuition.
Then an unusual opportunity presented itself.
read on - http://articles.latimes.com/2004/apr/02/science/sci-humantest2
Traci Johnson joined a clinical trial of an antidepressant to pay for college. The devout woman ended up taking her own life.
THE NATION
COLUMN ONEApril 02, 2004
Alan Zarembo and Benedict Carey , Times Staff WritersINDIANAPOLIS — Traci Johnson believed it was God's plan for her to leave home to attend a tiny Bible college here -- and she prayed every day for the Lord to provide for her tuition.
Then an unusual opportunity presented itself.
read on - http://articles.latimes.com/2004/apr/02/science/sci-humantest2
justAna: People close to Trace Johnson left three comments anonymously
justAna: People close to Trace Johnson left three comments anonymously
I received three comments of someone or more than one person that claims they mourn Traci's death and was very close to her. These are the comments:
melissa said...
I just wanted to comment here, that I too remember dearest Tracy. I was all too close to her this very night that she passed and my prayers continue for her family that survived her passing. Now 6 years later and my heart still bleeds a bit as we pass by this season of life again and mourn her loss.
With Love,
-Someone who was Called to the scene of passing-
February 14, 2010 6:25 PM
This one at this post and:
AnnaJ said...
I knew Traci. What a loss! We still carry the pain and sadness of her absence from our lives.
February 27, 2010 3:16 PM
Anonymous said...
Thank you for honoring Traci. She is sorely missed. We knew Traci. She was a part of our lives. The sheer devistation has not healed even after 7 years. We are still suffering from the absence of this wonderful person in our lives.
February 27, 2010 3:23 PM
these at my other blog here.
Thank you for leaving these messages but I will never understand why people who are close to Traci Johnson says nothing, keep in silence and don't fight for justice to what was done to this 19 years-old healthy girl who was murdered at Eli-Lilly's facilities after taking Cymbalta and having as side effect drug-induced suicidal ideation. She hanged herself but keep in mind that she was not testing Cymbalta as an antidepressant but as a medicine for urinary incontinence and that she has never had any kind of mental disease since it was one of the requirements to be a volunteer in that clinical trial. Eli-Lilly wanted healthy people for this clinical trial and Traci Johnson was accepted after being examined and classified as not having any kind of mental disease. We are talking about a girl who just volunteered to a clinical trial because her father was jobless and she was going to be paid $ 150 a day.
I don't understand why these people are commenting anonymously and since I started bloging I asked many people if they knew about Traci Johnson's parents, relatives or friends.
If you keep on silent and don't fight for justice like Sara Carlin's parents and others I have to admit that I have to believe in those who claim that Elli Lilly has payed the family to keep silent.
Unacceptable.
I received three comments of someone or more than one person that claims they mourn Traci's death and was very close to her. These are the comments:
melissa said...
I just wanted to comment here, that I too remember dearest Tracy. I was all too close to her this very night that she passed and my prayers continue for her family that survived her passing. Now 6 years later and my heart still bleeds a bit as we pass by this season of life again and mourn her loss.
With Love,
-Someone who was Called to the scene of passing-
February 14, 2010 6:25 PM
This one at this post and:
AnnaJ said...
I knew Traci. What a loss! We still carry the pain and sadness of her absence from our lives.
February 27, 2010 3:16 PM
Anonymous said...
Thank you for honoring Traci. She is sorely missed. We knew Traci. She was a part of our lives. The sheer devistation has not healed even after 7 years. We are still suffering from the absence of this wonderful person in our lives.
February 27, 2010 3:23 PM
these at my other blog here.
Thank you for leaving these messages but I will never understand why people who are close to Traci Johnson says nothing, keep in silence and don't fight for justice to what was done to this 19 years-old healthy girl who was murdered at Eli-Lilly's facilities after taking Cymbalta and having as side effect drug-induced suicidal ideation. She hanged herself but keep in mind that she was not testing Cymbalta as an antidepressant but as a medicine for urinary incontinence and that she has never had any kind of mental disease since it was one of the requirements to be a volunteer in that clinical trial. Eli-Lilly wanted healthy people for this clinical trial and Traci Johnson was accepted after being examined and classified as not having any kind of mental disease. We are talking about a girl who just volunteered to a clinical trial because her father was jobless and she was going to be paid $ 150 a day.
I don't understand why these people are commenting anonymously and since I started bloging I asked many people if they knew about Traci Johnson's parents, relatives or friends.
If you keep on silent and don't fight for justice like Sara Carlin's parents and others I have to admit that I have to believe in those who claim that Elli Lilly has payed the family to keep silent.
Unacceptable.
Thursday, 25 February 2010
Wednesday, 24 February 2010
Panorama found 'in breach of BBC rules' - episode looked at the long-term use of drugs in children with ADHD
Panorama found 'in breach of BBC rules'
http://news.bbc.co.uk/1/hi/entertainment/8534718.stm
The episode looked at the long-term use of drugs in children with ADHD
BBC current affairs programme Panorama will broadcast an apology after the corporation's independent watchdog said it breached editorial guidelines.
The BBC Trust Editorial Standards Committee said it did not accurately report a study into Attention Deficit Hyperactivity Disorder (ADHD).
What Next for Craig? looked at the use of drugs used to control the condition when it aired in November 2007.
The Trust said the show did not intend to mislead, but "distorted" some facts.
An apology will be broadcast during a future edition of Panorama, and the BBC's deputy director general Mark Byford will meet the committee to ensure the breaches are not repeated.
Failings
The committee partially upheld an appeal over a complaint.
It was ruled that Panorama did not accurately report the findings of a follow-up scientific study comparing the treatment of children with ADHD.
The programme makers have been accused of relying on the views of one scientist and viewers were not told that there is a wide range of views on the subject.
The episode also looked into the long-term use of stimulant drugs such as Ritalin.
But it was ruled that show failed to accurately report the findings of a three-year study which was conducted in the US.
Although the committee said that programme makers did not intend to mislead the audience, it did point out that "the programme failed to meet the requirements of impartiality in that the programme makers were not fair and open minded when examining the evidence and weighing all the material facts, nor were they even handed in their approach to the subject".
The report concluded: "The Editorial Standards Committee (ESC) expects the highest standards from Panorama as BBC One's flagship current affairs programme, and this programme failed to reach those standards.
"Due to the serious nature of the breaches the ESC will apologise to the complainant on behalf of the BBC and require the broadcast of a correction."
http://news.bbc.co.uk/1/hi/entertainment/8534718.stm
The episode looked at the long-term use of drugs in children with ADHD
BBC current affairs programme Panorama will broadcast an apology after the corporation's independent watchdog said it breached editorial guidelines.
The BBC Trust Editorial Standards Committee said it did not accurately report a study into Attention Deficit Hyperactivity Disorder (ADHD).
What Next for Craig? looked at the use of drugs used to control the condition when it aired in November 2007.
The Trust said the show did not intend to mislead, but "distorted" some facts.
An apology will be broadcast during a future edition of Panorama, and the BBC's deputy director general Mark Byford will meet the committee to ensure the breaches are not repeated.
Failings
The committee partially upheld an appeal over a complaint.
It was ruled that Panorama did not accurately report the findings of a follow-up scientific study comparing the treatment of children with ADHD.
The programme makers have been accused of relying on the views of one scientist and viewers were not told that there is a wide range of views on the subject.
The episode also looked into the long-term use of stimulant drugs such as Ritalin.
But it was ruled that show failed to accurately report the findings of a three-year study which was conducted in the US.
Although the committee said that programme makers did not intend to mislead the audience, it did point out that "the programme failed to meet the requirements of impartiality in that the programme makers were not fair and open minded when examining the evidence and weighing all the material facts, nor were they even handed in their approach to the subject".
The report concluded: "The Editorial Standards Committee (ESC) expects the highest standards from Panorama as BBC One's flagship current affairs programme, and this programme failed to reach those standards.
"Due to the serious nature of the breaches the ESC will apologise to the complainant on behalf of the BBC and require the broadcast of a correction."
Monday, 22 February 2010
Sunday, 21 February 2010
Psychdata - Doctoring the Evidence: GlaxoSmithKline
Psychdata - Dedicated to exposing the fraud of psychiatry: Doctoring the Evidence: GlaxoSmithKline Pushes Depression Drug
Tuesday, August 14, 2007
Doctoring the Evidence: GlaxoSmithKline Pushes Depression Drug
http://corpwatch.org/article.php?id=14606
Doctoring the Evidence: GlaxoSmithKline Pushes Depression Drug
by Shelley Jofre, Special to Corp Watch
July 30th, 2007
A striking young woman with a talent for painting, Sharise Gatchell was - like many teenagers - painfully self-conscious. At 14, she moved with her family from South Africa to England where at first she found it hard to make friends. By the age of 16 she was acutely embarrassed that her periods hadn't started and felt she was sweating excessively. Just the sort of thing to make adolescence even more painful than usual. Her mother, Stephanie, took her to see a consultant physician at the local hospital. Stephanie Gatchell recalls:
.............
...........................
Meanwhile, Stephanie Gatchell and her husband have moved away from the home that holds so many awful memories, to start a new life in Ireland. They can't forgive GlaxoSmithKline for concealing what it knew about paroxetine:
"I can't understand how they could possibly be so devious, and all just because of profit. I think the decision-makers in that company should be brought to justice. They have a lot to explain."
*Shelley Jofre is a reporter with BBC TV's flagship current affairs program: Panorama. To learn more about Sharise Gatchell, see http://www.gevil.netopti.net/.
GlaxoSmithKline issued a statement in response to Shelley Jofre's investigation.
Posted by Psychdata at 9:30 PM
Tuesday, August 14, 2007
Doctoring the Evidence: GlaxoSmithKline Pushes Depression Drug
http://corpwatch.org/article.php?id=14606
Doctoring the Evidence: GlaxoSmithKline Pushes Depression Drug
by Shelley Jofre, Special to Corp Watch
July 30th, 2007
A striking young woman with a talent for painting, Sharise Gatchell was - like many teenagers - painfully self-conscious. At 14, she moved with her family from South Africa to England where at first she found it hard to make friends. By the age of 16 she was acutely embarrassed that her periods hadn't started and felt she was sweating excessively. Just the sort of thing to make adolescence even more painful than usual. Her mother, Stephanie, took her to see a consultant physician at the local hospital. Stephanie Gatchell recalls:
.............
...........................
Meanwhile, Stephanie Gatchell and her husband have moved away from the home that holds so many awful memories, to start a new life in Ireland. They can't forgive GlaxoSmithKline for concealing what it knew about paroxetine:
"I can't understand how they could possibly be so devious, and all just because of profit. I think the decision-makers in that company should be brought to justice. They have a lot to explain."
*Shelley Jofre is a reporter with BBC TV's flagship current affairs program: Panorama. To learn more about Sharise Gatchell, see http://www.gevil.netopti.net/.
GlaxoSmithKline issued a statement in response to Shelley Jofre's investigation.
Posted by Psychdata at 9:30 PM
CorpWatch : Doctoring the Evidence: GlaxoSmithKline Pushes Depression Drug
CorpWatch : Doctoring the Evidence: GlaxoSmithKline Pushes Depression Drug
http://corpwatch.org/article.php?id=14606
by Shelley Jofre, Special to Corp Watch
July 30th, 2007
A striking young woman with a talent for painting, Sharise Gatchell was - like many teenagers - painfully self-conscious. At 14, she moved with her family from South Africa to England where at first she found it hard to make friends. By the age of 16 she was acutely embarrassed that her periods hadn't started and felt she was sweating excessively. Just the sort of thing to make adolescence even more painful than usual. Her mother, Stephanie, took her to see a consultant physician at the local hospital. Stephanie Gatchell recalls:
"During that consultation she became a bit emotional because she was explaining to him about the problems she had and how it affected her social life. Then she started crying
read on -
http://corpwatch.org/article.php?id=14606
http://corpwatch.org/article.php?id=14606
by Shelley Jofre, Special to Corp Watch
July 30th, 2007
A striking young woman with a talent for painting, Sharise Gatchell was - like many teenagers - painfully self-conscious. At 14, she moved with her family from South Africa to England where at first she found it hard to make friends. By the age of 16 she was acutely embarrassed that her periods hadn't started and felt she was sweating excessively. Just the sort of thing to make adolescence even more painful than usual. Her mother, Stephanie, took her to see a consultant physician at the local hospital. Stephanie Gatchell recalls:
"During that consultation she became a bit emotional because she was explaining to him about the problems she had and how it affected her social life. Then she started crying
read on -
http://corpwatch.org/article.php?id=14606
Mark Harvey takes 7 years to tell Seroxat suicide client he had no case
http://groups.yahoo.com/group/uksurvivors/message/55547
Seroxat lawyer can see NO LINK with Seroxat & client suicide !
i...@lancashirecaravans.co.uk View profile We had some bad news today, the solicitors acting on our behalf, wrote to us saying they could not find a link between Susan trying to kill herself (several times) and the use of Seroxat, and that they will no longer handle our case, they have been dealing with this for the past 7 years or so.... and after this time, that is their conclusion.... useless, all they see is text book stuff, they cannot see outside of the box the way I can. Now, we have less than 8 weeks to beat the 10 year time limit to get this to court, I want to know how I can at least start court proceedings against Glaxo without the aid of solicitors, can someone advise us on how to start the proceedings in court. Simon
More options Feb 8 2007, 5:25 pm
Newsgroups: uk.legal
From: si...@lancashirecaravans.co.uk
Date: 8 Feb 2007 09:25:48 -0800
Local: Thurs, Feb 8 2007 5:25 pm
Subject: how do I start court proceedings
We had some bad news today, the solicitors acting on our behalf, wrote
to us saying they could not find a link between Susan trying to kill
herself (several times) and the use of Seroxat, and that they will no
longer handle our case, they have been dealing with this for the past
7 years or so.... and after this time, that is their conclusion....
useless, all they see is text book stuff, they cannot see outside of
the box the way I can.
Now, we have less than 8 weeks to beat the 10 year time limit to get
this to court, I want to know how I can at least start court
proceedings against Glaxo without the aid of solicitors, can someone
advise us on how to start the proceedings in court.
Simon
http://groups.google.com/group/uk.legal/browse_thread/thread/f4a60cf8dc96c472/ef879327dd8aa07b?hl=en&ie=UTF-8&q=shelley+jofre&pli=1
More options Feb 8 2007, 5:25 pm
Newsgroups: uk.legal
From: si...@lancashirecaravans.co.uk
Date: 8 Feb 2007 09:25:48 -0800
Local: Thurs, Feb 8 2007 5:25 pm
Subject: how do I start court proceedings
We had some bad news today, the solicitors acting on our behalf, wrote
to us saying they could not find a link between Susan trying to kill
herself (several times) and the use of Seroxat, and that they will no
longer handle our case, they have been dealing with this for the past
7 years or so.... and after this time, that is their conclusion....
useless, all they see is text book stuff, they cannot see outside of
the box the way I can.
Now, we have less than 8 weeks to beat the 10 year time limit to get
this to court, I want to know how I can at least start court
proceedings against Glaxo without the aid of solicitors, can someone
advise us on how to start the proceedings in court.
Simon
http://groups.google.com/group/uk.legal/browse_thread/thread/f4a60cf8dc96c472/ef879327dd8aa07b?hl=en&ie=UTF-8&q=shelley+jofre&pli=1
Saturday, 20 February 2010
Seroxat USERS collaborate with GSK & MHRA to approve Patient Info Leaflet
http://www.mhra.gov.uk/home/groups/pl-p/documents/committeedocument/con003475.pdf
6.2 DRAFT SEROXAT PATIENT INFORMATION LEAFLET
6.2.1 The Group was informed that the Seroxat Patient Information Leaflet (PIL) will form a key component of any communications around the time of European Commission Decision in relation to the Article 31 referral for paroxetine.
6.2.2 Upon request GSK has submitted an amended version of the Seroxat PIL that reflects the changes to the product information for prescribers recommended
H:JW/SSRIEWGMINSMTG13.doc
by the recommended by the Committee for Medicinal Products for Human Use. GSK has also outlined its plans to user test this leaflet using a company called Consumation. The Group was informed that the MHRA was also planning to have users independently test the leaflet and commitments had been given to various stakeholders that their comments would be sought.
6.2.3 The Group was informed that GSK was provided with initial feedback on the draft Seroxat PIL during a meeting held between the MHRA and GSK on 15 July 2004. In light of these discussions GSK has provided a further draft which takes these comments into account. The Group had the following comments about the content and format of the revised draft Seroxat PIL:
extract from -
COMMITTEE ON SAFETY OF MEDICINES
EXPERT GROUP ON SAFETY OF SSRIs
MINUTES OF THE MEETING OF THE CSM EXPERT GROUP ON THE SAFETY OF SSRIS HELD ON WEDNESDAY 23 JULY 2004 AT 10AM IN CR1 AT MARKET TOWERS.
6.2 DRAFT SEROXAT PATIENT INFORMATION LEAFLET
6.2.1 The Group was informed that the Seroxat Patient Information Leaflet (PIL) will form a key component of any communications around the time of European Commission Decision in relation to the Article 31 referral for paroxetine.
6.2.2 Upon request GSK has submitted an amended version of the Seroxat PIL that reflects the changes to the product information for prescribers recommended
H:JW/SSRIEWGMINSMTG13.doc
by the recommended by the Committee for Medicinal Products for Human Use. GSK has also outlined its plans to user test this leaflet using a company called Consumation. The Group was informed that the MHRA was also planning to have users independently test the leaflet and commitments had been given to various stakeholders that their comments would be sought.
6.2.3 The Group was informed that GSK was provided with initial feedback on the draft Seroxat PIL during a meeting held between the MHRA and GSK on 15 July 2004. In light of these discussions GSK has provided a further draft which takes these comments into account. The Group had the following comments about the content and format of the revised draft Seroxat PIL:
extract from -
COMMITTEE ON SAFETY OF MEDICINES
EXPERT GROUP ON SAFETY OF SSRIs
MINUTES OF THE MEETING OF THE CSM EXPERT GROUP ON THE SAFETY OF SSRIS HELD ON WEDNESDAY 23 JULY 2004 AT 10AM IN CR1 AT MARKET TOWERS.
Friday, 19 February 2010
Stalking: false claims of victimisation ..........thanks to our Australian readers for this topical article ROFL
The British Journal of Psychiatry 174: 170-172 (1999)
© 1999 The Royal College of Psychiatrists
http://bjp.rcpsych.org/cgi/content/abstract/174/2/170
Stalking: false claims of victimisation
M Pathe, PE Mullen and R Purcell
Victorian Institute of Forensic Mental Health, Rosanna, Australia.
BACKGROUND: False allegations of victimisation although uncommon are important to recognise. This paper examines those who falsely claim to have been the victims of stalking. AIMS: To highlight the phenomenon of false victims of stalking. METHOD: Twelve individuals who falsely claimed to be victims of stalking were compared with a group of 100 true stalking victims. RESULTS: False stalking victims presented for help earlier than real victims and were less likely to claim harassment via letters. They reported equivalent levels of violence directed at themselves but seldom claimed others were attacked. Five types of false claimants were recognisable. False victims consumed more medical services than genuine stalking victims and they were more likely to be embroiled in legal action. They reported similar levels of distress with suicidal ruminations in over 40%. CONCLUSIONS: The current interest in stalking is promoting false claims of being stalked. Early identification of these cases and appropriate intervention are essential to both minimising abuses of resources available to true victims and equally to ensure appropriate care for those who express their own disordered state in false claims of victimisation.
© 1999 The Royal College of Psychiatrists
http://bjp.rcpsych.org/cgi/content/abstract/174/2/170
Stalking: false claims of victimisation
M Pathe, PE Mullen and R Purcell
Victorian Institute of Forensic Mental Health, Rosanna, Australia.
BACKGROUND: False allegations of victimisation although uncommon are important to recognise. This paper examines those who falsely claim to have been the victims of stalking. AIMS: To highlight the phenomenon of false victims of stalking. METHOD: Twelve individuals who falsely claimed to be victims of stalking were compared with a group of 100 true stalking victims. RESULTS: False stalking victims presented for help earlier than real victims and were less likely to claim harassment via letters. They reported equivalent levels of violence directed at themselves but seldom claimed others were attacked. Five types of false claimants were recognisable. False victims consumed more medical services than genuine stalking victims and they were more likely to be embroiled in legal action. They reported similar levels of distress with suicidal ruminations in over 40%. CONCLUSIONS: The current interest in stalking is promoting false claims of being stalked. Early identification of these cases and appropriate intervention are essential to both minimising abuses of resources available to true victims and equally to ensure appropriate care for those who express their own disordered state in false claims of victimisation.
Fiddaman's publisher Jason Pegler's books available discount price at CCHR/Scientology
A Can Of Madness
http://www.cchr.org.uk/products/product_info.php?cPath=21_22&products_id=30&osCsid=5d1f2ddc99bc7eaf9bd4747002037c1b
[ACOM01] £9.99
Author: Jason Pegler
A vivid, honest and sometimes disturbing memoir about the experience of having a diagnosis of manic-depression. It was written using extracts from a diary written at the time of the author's flights into mania and his descents into depression. Like other books in this genre, the author is often painfully honest about his experiences. He recounts a dizzying, dark and sometimes euphoric journey through a world of elation, despair, binge drinking, drugs, raves and psychiatric wards. As well as attempting to educate the reader, the book also provides optimism and hope, showing that it is finally possible to learn to live with, and accept, having a mental health problem.
This product was added to our catalog on Tuesday, 17. July 2007.
[ACOM01] £9.99
Author: Jason Pegler
A vivid, honest and sometimes disturbing memoir about the experience of having a diagnosis of manic-depression. It was written using extracts from a diary written at the time of the author's flights into mania and his descents into depression. Like other books in this genre, the author is often painfully honest about his experiences. He recounts a dizzying, dark and sometimes euphoric journey through a world of elation, despair, binge drinking, drugs, raves and psychiatric wards. As well as attempting to educate the reader, the book also provides optimism and hope, showing that it is finally possible to learn to live with, and accept, having a mental health problem.
This product was added to our catalog on Tuesday, 17. July 2007.
Wednesday, 17 February 2010
The Evidence, however is clear ... Fiddaman blog bought by Scientology
Subscribe to:
Posts (Atom)